A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
National Cancer Institute (NCI)
Incyte Corporation
Incyclix Bio
Terremoto Biosciences Inc.
Ensem Therapeutics
Eli Lilly and Company
University of Oklahoma
Avenzo Therapeutics, Inc.
Case Comprehensive Cancer Center